What Investors Are Watching Ahead of Zogenix's FDA Approval Decision

By: via Benzinga
Although it received FDA approval in 2013, Zogenix, Inc. (NASDAQ: ZGNX) had a lackluster 2014. The stock fell about 70 percent on the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.